Anderson Cynthia Lynn bought VTGN
June 30, 2025 · Form 4 insider transaction
Anderson Cynthia Lynn bought 6,617 shares of Vistagen Therapeutics, Inc. at $1.70 per share, a transaction worth $11.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,617
Price
$1.70
Total value
$11.2K
InsiderAnderson Cynthia Lynn
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 30, 2025
Filing dateJuly 1, 2025
Shares owned after12,801
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).